Gland Pharma Limited — Others, 10-04-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Gland Pharma Limited has announced a board meeting to discuss the financial results for the quarter and half-year ended March 31, 2025. Additionally, a Confirmation Certificate from MUFG Intime India Pvt. Ltd confirms that the securities received for dematerialization during the quarter were processed correctly and listed on the relevant stock exchanges. This update ensures operational transparency and may positively influence investor sentiment by reinforcing the company's governance and compliance practices. However, further financial details during the meeting will be crucial for assessing the company’s performance outlook.